JP2017201255A5 - - Google Patents

Download PDF

Info

Publication number
JP2017201255A5
JP2017201255A5 JP2016092898A JP2016092898A JP2017201255A5 JP 2017201255 A5 JP2017201255 A5 JP 2017201255A5 JP 2016092898 A JP2016092898 A JP 2016092898A JP 2016092898 A JP2016092898 A JP 2016092898A JP 2017201255 A5 JP2017201255 A5 JP 2017201255A5
Authority
JP
Japan
Prior art keywords
marker
level
cancer
subject
sample
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2016092898A
Other languages
English (en)
Japanese (ja)
Other versions
JP6755703B2 (ja
JP2017201255A (ja
Filing date
Publication date
Application filed filed Critical
Priority to JP2016092898A priority Critical patent/JP6755703B2/ja
Priority claimed from JP2016092898A external-priority patent/JP6755703B2/ja
Publication of JP2017201255A publication Critical patent/JP2017201255A/ja
Publication of JP2017201255A5 publication Critical patent/JP2017201255A5/ja
Application granted granted Critical
Publication of JP6755703B2 publication Critical patent/JP6755703B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2016092898A 2016-05-05 2016-05-05 がんの検出法 Active JP6755703B2 (ja)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP2016092898A JP6755703B2 (ja) 2016-05-05 2016-05-05 がんの検出法

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP2016092898A JP6755703B2 (ja) 2016-05-05 2016-05-05 がんの検出法

Publications (3)

Publication Number Publication Date
JP2017201255A JP2017201255A (ja) 2017-11-09
JP2017201255A5 true JP2017201255A5 (enExample) 2019-06-06
JP6755703B2 JP6755703B2 (ja) 2020-09-16

Family

ID=60265030

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2016092898A Active JP6755703B2 (ja) 2016-05-05 2016-05-05 がんの検出法

Country Status (1)

Country Link
JP (1) JP6755703B2 (enExample)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN111208229B (zh) * 2020-01-17 2021-02-26 华中农业大学 蛋鸡低骨密度联合诊断血清代谢标志物的筛选方法及其应用
CN120490483A (zh) * 2025-05-15 2025-08-15 华中科技大学同济医学院附属同济医院 一种黑色素瘤预后生物标志物的组合及其应用

Similar Documents

Publication Publication Date Title
Duijvesz et al. Immuno‐based detection of extracellular vesicles in urine as diagnostic marker for prostate cancer
Farzin et al. Recent advances in design of electrochemical affinity biosensors for low level detection of cancer protein biomarkers using nanomaterial-assisted signal enhancement strategies
JP2014144959A5 (enExample)
Gruver et al. Selective immunohistochemical markers to distinguish between metastatic high-grade urothelial carcinoma and primary poorly differentiated invasive squamous cell carcinoma of the lung
Broersen et al. Clinical application of circulating tumor cells in breast cancer
WO2014140933A3 (en) Method for the prognosis and treatment of cancer metastasis
JP2015523569A5 (enExample)
WO2015071669A3 (en) Materials and methods for diagnosis and prognosis of liver cancer
JP2012073260A5 (enExample)
Fatourou et al. Keratin 19 protein expression is an independent predictor of survival in human hepatocellular carcinoma
WO2014184679A3 (en) Method for the prognosis and treatment of renal cell carcinoma metastasis
Leung et al. Ovarian cancer biomarkers: current state and future implications from high-throughput technologies
Szarvas et al. Validation of circulating MMP-7 level as an independent prognostic marker of poor survival in urinary bladder cancer
JP2016536568A5 (enExample)
WO2015077382A3 (en) Combined cytology and molecular testing for early detection of esophageal adenocarcinoma
Simão et al. Plasma osteopontin is a biomarker for the severity of alcoholic liver cirrhosis, not for hepatocellular carcinoma screening
EA201391378A1 (ru) Обнаружение биомаркеров в сложных биологических жидкостях с использованием библиотек и диагностических наборов на основе бусин или частиц и лекарственные средства
RU2012148244A (ru) Способ диагностики онкологических заболеваний и иммуноферментный набор для его осуществления
GB201021623D0 (en) Detection of acute myeloid leukaemia
WO2014161910A3 (en) Methods and arrays for use in biomarker detection for prostate cancer
Alinezhad et al. Stratification of aggressive prostate cancer from indolent disease—Prospective controlled trial utilizing expression of 11 genes in apparently benign tissue
JP2019516104A5 (enExample)
Kang et al. Isolation of Circulating Biomarkers for Liquid Biopsy using Immunoaffinity‐Based Stimuli‐Responsive Hybrid Hydrogel Beads
RU2018123581A (ru) Способ для выделения раковых стволовых клеток
WO2015023661A3 (en) Biomarkers for prostate cancer